Homocysteine level and risk of different stroke types: A meta-analysis of prospective observational studies

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 11, 2014, Pages 1158-1165

  He, Yusheng ^a   Li, Yunxia ^a   Chen, Yuhui ^a   Feng, Liang ^a   Nie, Zhiyu ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Homocysteine; Ischemic stroke; Stroke

Indexed keywords

HOMOCYSTEINE;

ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; HUMAN; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RECURRENT DISEASE; SCORING SYSTEM; SENSITIVITY ANALYSIS;

EID: 84909586908     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.05.011     Document Type: Article

References (31)

1. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
2. Feigin V.L., Lawes C.M., Bennett D.A., Anderson C.S. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003, 2:43-53.
3. American Heart Association Heart disease and stroke statistics 2005, American heart association, Dallas. Texas, Availableat:, [accessed 20.05.13]. http://www.Americanheart.Org/downloadable/heart/1105390918119hdsstats2005update.Pdf.
4. Bostom A.G., Rosenberg I.H., Silbershatz H., Jacques P.F., Selhub J., D'Agostino R.B., et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 1999, 131:352-355.
5. Sacco R.L., Anand K., Lee H.S., Boden-Albala B., Stabler S., Allen R., et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the Northern Manhattan Study. Stroke 2004, 35:2263-2269.
6. Iso H., Moriyama Y., Sato S., Kitamura A., Tanigawa T., Yamagishi K., et al. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation 2004, 109:2766-2772.
7. Virtanen J.K., Voutilainen S., Happonen P., Alfthan G., Kaikkonen J., Mursu J., et al. Serum homocysteine, folate and risk of stroke: Kuopio ischaemic heart disease risk factor (KIHD) study. Eur J Cardiovasc Prev Rehabil 2005, 12:369-375.
8. Bos M.J., van Goor M.L., Koudstaal P.J., Dippel D.W. Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischaemic stroke or TIA. J Neurol 2005, 252:332-337.
9. Zhang W., Sun K., Chen J., Liao Y., Qin Q., Ma A., et al. High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. Clin Sci (Lond) 2010, 118:187-194.
10. Verhoef P., Hennekens C.H., Malinow M.R., Kok F.J., Willett W.C., Stampfer M.J. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 1994, 25:1924-1930.
11. Fallon U.B., Elwood P., Ben-Shlomo Y., Ubbink J.B., Greenwood R., Smith G.D. Homocysteine and ischaemic stroke in men: the Caerphilly study. J Epidemiol Community Health 2001, 55:91-96.
12. Sun Y., Chien K.L., Hsu H.C., Su T.C., Chen M.F., Lee Y.T. Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese. 12-year prospective cohort study. Circ J 2009, 73:1423-1430.
13. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 1995, 274:1049-1057.
14. Moller J., Nielsen G.M., Tvedegaard K.C., Andersen N.T., Jorgensen P.E. A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. Scand J Clin Lab Invest 2000, 60:491-499.
15. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. J Am Med Assoc 2002, 288:2015-2022. Collaboration HS.
16. Ji Y., Tan S., Xu Y., Chandra A., Shi C., Song B., et al. Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis. Neurology 2013, 81:1298-1307.
17. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. J Am Med Assoc 2000, 283:2008-2012.
18. Iso H., Rexrode K., Hennekens C.H., Manson J.E. Application of computer tomography-oriented criteria for stroke subtype classification in a prospective study. Ann Epidemiol 2000, 10:81-87.
19. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
20. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
21. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
22. Bamford J., Sandercock P., Dennis M., Warlow C., Jones L., McPherson K., et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry 1988, 51:1373-1380.
23. Stehouwer C.D., Weijenberg M.P., van den Berg M., Jakobs C., Feskens E.J., Kromhout D. Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up. Arterioscler Thromb Vasc Biol 1998, 18:1895-1901.
24. Bots M.L., Launer L.J., Lindemans J., Hoes A.W., Hofman A., Witteman J.C., et al. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med 1999, 159:38-44.
25. Fallon U.B., Virtamo J., Young I., McMaster D., Ben-Shlomo Y., Wood N., et al. Homocysteine and cerebral infarction in finnish male smokers. Stroke 2003, 34:1359-1363.
26. Tanne D., Haim M., Goldbourt U., Boyko V., Doolman R., Adler Y., et al. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke 2003, 34:632-636.
27. Boysen G., Truelsen T. Prevention of recurrent stroke. Neurol Sci 2000, 21:67-72.
28. Toole J.F., Malinow M.R., Chambless L.E., Spence J.D., Pettigrew L.C., Howard V.J., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. J Am Med Assoc 2004, 291:565-575.
29. Nygard O., Vollset S.E., Refsum H., Stensvold I., Tverdal A., Nordrehaug J.E., et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. J Am Med Assoc 1995, 274:1526-1533.
30. Harker L.A., Slichter S.J., Scott C.R., Ross R. Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med 1974, 291:537-543.
31. Harker L.A., Ross R., Slichter S.J., Scott C.R. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976, 58:731-741.